ethoglucid has been researched along with Urinary Bladder Neoplasms in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (76.60) | 18.7374 |
| 1990's | 10 (21.28) | 18.2507 |
| 2000's | 1 (2.13) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ay, R; Dalesio, O; de Pauw, M; Debruyne, F; Kurth, KH; Pavone-Macaluso, M; Schröder, FH; ten Kate, F; Tunn, U | 1 |
| Lum, BL | 1 |
| Koontz, WW | 1 |
| Lum, BL; Torti, FM | 2 |
| Smith, PH | 3 |
| Kratzik, C; Lunglmayr, G; Mattausch, M | 1 |
| Baumgartner, G | 1 |
| Fitzpatrick, JM; Khan, O; Oliver, RT; Riddle, PR | 2 |
| Larsen, J | 1 |
| Colleen, S; Ek, A; Hellsten, S; Lindholm, CE | 1 |
| Albrecht, W; Bucher, A; Donner, G; Flamm, J; Havelec, L; Höltl, W | 1 |
| Ay, R; de Pauw, M; Debruyne, F; Kurth, K; Pavone-Macaluso, M; Schröder, FH; Sylvester, R; ten Kate, F; Tunn, U | 1 |
| Duque, JL; Loughlin, KR | 1 |
| Mäntylä, M; Oravisto, KJ | 1 |
| Soloway, MS | 1 |
| Alfthan, O; Kiistala, U; Lassus, A; Pyrhönen, S; Vuori, J | 1 |
| Nielsen, HV; Thybo, E | 1 |
| Lane, V; O'Flynn, JD; SMith, JM | 1 |
| Bastable, J; Glashan, RW; Richards, B; Robinson, MR; Shetty, MB; Smith, PH | 1 |
| Hannestad, R; Otnes, B | 1 |
| Debruyne, FM; Kurth, KH; Oosterlinck, W; van der Meijden, AP | 1 |
| Albrecht, W; Hasun, R; Hoeltl, W | 1 |
| Crawford, ED; Thrasher, JB | 1 |
| Albrecht, W; Hasun, R; Hoeltl, W; Marberger, M | 1 |
| Bucher, A; Flamm, J | 1 |
| Abels, J; Hagemeyer, A; Kurth, KH; Sonneveld, P | 1 |
| Albrecht, W; Bucher, A; Flamm, J; Höltl, W | 1 |
| Hall, MH; Mufti, GR; Virdi, JS | 1 |
| King, M; Trybula, M | 1 |
| Dona, S; Flamm, J; Kühnel, W | 1 |
| de Pauw, M; Debruyne, F; Kurth, K; Pavone-Macaluso, M; Schroeder, FH; Senge, T; Sylvester, R; ten Kate, F | 1 |
| Groos, E; Masters, JR | 1 |
| Groos, E; Masters, JR; Walker, L | 1 |
| English, PJ; Hepburn, PJ; Masters, JR; Parris, CN; Walker, MC | 1 |
| Chisholm, GD; Elton, RA; Hargreave, TB; Newsam, JE; Smith, G | 1 |
| English, P; Masters, JR; Newman, B; Parris, CN; Riddle, P; Walker, MC | 1 |
| Frimodt-Möller, PC; Mathiasen, H; Nielsen, HV | 1 |
| Lawson, AH; Stewart, RJ; Weaver, JP | 1 |
| Carpentier, PJ; de Pauw, M; Debruyne, FJ; Kurth, KH; Riedl, H; Senge, T; Sylvester, R | 1 |
| Fritjofsson, A; Larson, A | 1 |
| Pavone-Macaluso, M | 1 |
| Fingerhut, B; Romas, NA; Veenema, RJ | 1 |
| Riddle, PR | 1 |
9 review(s) available for ethoglucid and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Intravesical chemotherapy of superficial bladder cancer.
Topics: Absorption; Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Endoscopy; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Molecular Weight; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
The biology and treatment of superficial bladder cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
Chemotherapy of bladder cancer: a review.
Topics: Administration, Topical; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Ethoglucid; Europe; Humans; Neoplasm Invasiveness; Prognosis; Random Allocation; Thiotepa; Urinary Bladder Neoplasms | 1981 |
[Progress in the internist treatment of bladder tumors].
Topics: Antineoplastic Agents; BCG Vaccine; Cisplatin; Doxorubicin; Ethoglucid; Humans; Leucovorin; Methotrexate; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1982 |
An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Epirubicin; Ethoglucid; Humans; Immunotherapy; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 2000 |
Intravesical and systemic chemotherapy of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Ethoglucid; FANFT; Female; Fluorouracil; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Thiotepa; Urinary Bladder Neoplasms | 1977 |
Complications of intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Ethoglucid; Humans; Mitomycin; Mitoxantrone; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Therapeutic approaches including interferon to carcinoma in situ of the bladder.
Topics: Administration, Topical; BCG Vaccine; Carcinoma in Situ; Cyclophosphamide; Doxorubicin; Ethoglucid; Humans; Interferons; Mitomycins; Papilloma; Thiotepa; Urinary Bladder Neoplasms | 1985 |
Chemotherapy for bladder cancer.
Topics: Administration, Topical; Alkylating Agents; Blood Cell Count; Carcinoma, Papillary; Cystitis; Cystoscopy; Ethers; Ethoglucid; Humans; Leukocyte Count; Leukopenia; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Postoperative Care; Preoperative Care; Thiotepa; Thrombocytopenia; Urinary Bladder Neoplasms; Urinary Catheterization; Urination Disorders | 1974 |
15 trial(s) available for ethoglucid and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alon
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Ethers; Ethoglucid; Humans; Male; Methods; Neoplasm Recurrence, Local; Random Allocation; Urethra; Urinary Bladder Neoplasms | 1984 |
Intravesical chemotherapy for superficial bladder cancer.
Topics: BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Doxorubicin; Ethoglucid; Follow-Up Studies; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Clinical trials in superficial and invasive bladder cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Ethoglucid; Humans; Methotrexate; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Chemotherapy of bladder cancer: a review.
Topics: Administration, Topical; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Ethoglucid; Europe; Humans; Neoplasm Invasiveness; Prognosis; Random Allocation; Thiotepa; Urinary Bladder Neoplasms | 1981 |
[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Combined Modality Therapy; Ethoglucid; Female; Follow-Up Studies; Hemocyanins; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Urinary Bladder Neoplasms | 1994 |
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Disease Progression; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Time Factors; Urinary Bladder Neoplasms | 1997 |
Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group.
Topics: Administration, Intravesical; Chemotherapy, Adjuvant; Doxorubicin; Epirubicin; Ethoglucid; Humans; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder Neoplasms | 1992 |
Prospective, randomized trial to evaluate high-versus low-dose interferon-alpha 2b versus conventional chemotherapy in prevention of the recurrence of superficial transitional cell carcinoma of the urinary bladder.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Drug Evaluation; Ethoglucid; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Urinary Bladder Neoplasms | 1992 |
How effective is topical alpha-2b interferon in preventing recurrence of superficial bladder cancer?
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Ethoglucid; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neoplasm Recurrence, Local; Recombinant Proteins; Urinary Bladder Neoplasms | 1991 |
Adjuvant topical chemotherapy versus immunotherapy in primary superficial transitional cell carcinoma of the bladder.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Combined Modality Therapy; Ethoglucid; Female; Hemocyanins; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Risk Factors; Urinary Bladder Neoplasms | 1991 |
Recurrent superficial transitional cell carcinoma of the bladder: adjuvant topical chemotherapy versus immunotherapy. A prospective randomized trial.
Topics: Administration, Intravesical; Aged; Antigens; Carcinoma, Transitional Cell; Ethers; Ethoglucid; Female; Hemocyanins; Humans; Immunotherapy; Male; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms | 1990 |
[Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Cystoscopy; Drug Administration Schedule; Ethers; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation; Urethra; Urinary Bladder Neoplasms | 1989 |
Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transur
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Ethers; Ethoglucid; Europe; Follow-Up Studies; Humans; Multicenter Studies as Topic; Prognosis; Random Allocation; Urinary Bladder; Urinary Bladder Neoplasms | 1989 |
Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Ethers; Ethoglucid; Humans; Neoplasm Recurrence, Local; Random Allocation; Urinary Bladder Neoplasms | 1985 |
Intravesical ethoglucid (Epodyl) for treatment of noninvasive bladder cancer (stage Ta).
Topics: Adult; Aged; Clinical Trials as Topic; Ethers; Ethoglucid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papilloma; Time Factors; Urinary Bladder Neoplasms | 1985 |
24 other study(ies) available for ethoglucid and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
[Effect of pathologic changes in the urinary epithelium on the absorption of ethoglucide (Epodyl) from the bladder].
Topics: Absorption; Epithelium; Ethers; Ethoglucid; Female; Humans; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
Prognostic factors influencing survival of patients receiving intravesical epodyl.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Drug Administration Schedule; Ethers; Ethoglucid; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms | 1982 |
Inactivation of Epodyl in aluminium foil cups as a cause of ineffective treatment of non-invasive bladder tumours.
Topics: Adult; Aged; Aluminum; Carcinoma, Papillary; Ethers; Ethoglucid; Female; Glass; Humans; Male; Middle Aged; Urinary Bladder Neoplasms | 1980 |
Intracavitary Epodyl for multiple non-invasive, highly differentiated bladder tumours.
Topics: Aged; Ethers; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms | 1980 |
[Treatment of bladder tumors].
Topics: Ethoglucid; Humans; Palliative Care; Thiotepa; Urinary Bladder Neoplasms | 1976 |
Treatment of Condyloma acuminata in male patients.
Topics: Adult; Condylomata Acuminata; Electrocoagulation; Ethoglucid; Humans; Immunotherapy; Male; Thiotepa; Urethral Neoplasms; Urinary Bladder Neoplasms; Vaccines | 1977 |
Epodyl treatment of bladder tumours.
Topics: Administration, Topical; Adult; Aged; Cystitis; Drug Evaluation; Ethers; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Papilloma; Urinary Bladder Neoplasms; Urinary Catheterization | 1979 |
Long-term follow-up in patients with superficial bladder tumours treated with intravesical Epodyl.
Topics: Carcinoma, Papillary; Ethers; Ethoglucid; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1979 |
Epodyl in management of noninvasive vesical neoplasms.
Topics: Diathermy; Ethers; Ethoglucid; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1978 |
Intravesical epodyl in the management of bladder tumors: combined experience of the Yorkshire Urological Cancer Research Group.
Topics: Adult; Aged; England; Ethers; Ethoglucid; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Remission, Spontaneous; Urinary Bladder; Urinary Bladder Neoplasms | 1977 |
[Epodyl treatment of bladder neoplasms].
Topics: Carcinoma, Papillary; Drug Evaluation; Ethers; Ethoglucid; Female; Humans; Male; Urinary Bladder Neoplasms | 1976 |
Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinoma.
Topics: Aged; Antineoplastic Agents; Doxorubicin; Ethoglucid; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Mitomycins; Urinary Bladder Neoplasms | 1990 |
Long-term follow-up of intravesical Epodyl therapy for superficial bladder cancer.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Ethers; Ethoglucid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Urinary Bladder Neoplasms | 1990 |
Superficial bladder cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Papillary; Doxorubicin; Ethoglucid; Female; Humans; Interferons; Mitomycin; Mitomycins; Prognosis; Retinoids; Thiotepa; Urinary Bladder Neoplasms | 1985 |
Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Epirubicin; Ethoglucid; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Osmolar Concentration; Stereoisomerism; Thiotepa; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Doxorubicin; Epirubicin; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Thiotepa; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Ethoglucid; Humans; Injections; Mitomycin; Mitomycins; Thiotepa; Time Factors; Tumor Stem Cell Assay; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Ethoglucid; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Invasiveness; Neoplasm Metastasis; Prognosis; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Colony-Forming Units Assay; Doxorubicin; Ethoglucid; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Polysorbates; Thiotepa; Urinary Bladder Neoplasms | 1987 |
Ureteropyeloscopic tumour treatment.
Topics: Administration, Topical; Adult; Carcinoma, Transitional Cell; Endoscopy; Ethers; Ethoglucid; Humans; Kidney Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms; Urinary Catheterization | 1988 |
The ultrastructure of transitional cell carcinomas of the human urinary bladder treated with ethoglucid or mitomycin.
Topics: Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Ethers; Ethoglucid; Humans; Microscopy, Electron; Middle Aged; Mitomycins; Urinary Bladder; Urinary Bladder Neoplasms | 1988 |
Intravesical chemotherapy--frequency of instillation.
Topics: Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Ethoglucid; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1985 |
Chemotherapy of vesical and prostatic tumours.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Cobalt Isotopes; Cystitis; Daunorubicin; Ethoglucid; Fluorouracil; Humans; Hydroxyurea; Male; Methotrexate; Mitomycins; Nitrogen Mustard Compounds; Papilloma; Prostatic Neoplasms; Thiotepa; Urinary Bladder Neoplasms | 1971 |
The management of superficial bladder tumours with intravesical Epodyl.
Topics: Alkylating Agents; Biopsy; Ethers; Ethers, Cyclic; Ethoglucid; Follow-Up Studies; Humans; Urinary Bladder Neoplasms | 1973 |